03 Profile
Hansard to 12 November 2026 · 31,484 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Diabetes
Rachel Batterham
Ph.D., SVP of medical innovation and external engagement, Lilly cardiometabolic health
Quoted in the press, across 1 topic since 29 Sept 2026
02 Quoted on · 1 of 29 topics
Rachel Batterham: key facts
- Kind of voice
- Sector leader
- Role
- Ph.D., SVP of medical innovation and external engagement, Lilly cardiometabolic health
- Quoted on
- Diabetes
- Press coverage
- Quoted in the press
- Most recently quoted
- 29 Sept 2026
04 On the record · press
What Rachel Batterham has said
- fiercepharma.com
Where Rachel Batterham has been quoted
- Novo, Lilly pit their GLP-1s against one another in diabetes and obesity as EASD kicks off in Milanfiercepharma.com · 29 Sept 2026
How we found the articles that name Rachel Batterham: we searched news for these terms.
- diabetes
- type 1 diabetes
- type 2 diabetes
- insulin
- diabetic
- diabetes prevention
Also searched with “diabetes” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Diabetes
Verbatim
“Head-to-head trials ultimately provide the best comparison of two medicines, but when we don't yet have those data, then other approaches can provide informative data points”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.